Total Payments
$621.96
2024 Payments
$261.65
Companies
12
Transactions
17
Medicare Patients
688
Medicare Billing
$92,129
Payment Breakdown by Category
Food & Beverage$423.01 (68.0%)
Education$198.95 (32.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $423.01 | 15 | 68.0% |
| Education | $198.95 | 2 | 32.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $204.62 | 2 | $0 (2024) |
| Incyte Corporation | $129.70 | 3 | $0 (2022) |
| ABBVIE INC. | $77.55 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $63.57 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $23.67 | 1 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $23.46 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.76 | 1 | $0 (2021) |
| Seagen Inc. | $20.87 | 1 | $0 (2021) |
| Astellas Pharma US Inc | $15.07 | 1 | $0 (2024) |
| Eisai Inc. | $13.85 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $261.65 | 9 | Janssen Biotech, Inc. ($104.67) |
| 2023 | $99.95 | 1 | Janssen Biotech, Inc. ($99.95) |
| 2022 | $111.43 | 2 | Incyte Corporation ($111.43) |
| 2021 | $148.93 | 5 | E.R. Squibb & Sons, L.L.C. ($63.57) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $13.76 | General |
| Category: Oncology | ||||||
| 11/13/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.08 | General |
| 08/06/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Oncology | ||||||
| 06/04/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $104.67 | General |
| Category: Oncology | ||||||
| 05/10/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Oncology | ||||||
| 05/03/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 06/15/2022 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $12.43 | General |
| Category: Oncology | ||||||
| 03/21/2022 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.00 | General |
| 10/01/2021 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE, JAKAFI | Food and Beverage | Cash or cash equivalent | $18.27 | General |
| Category: Oncology | ||||||
| 09/16/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $63.57 | General |
| Category: Oncology | ||||||
| 06/29/2021 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Hematology | ||||||
| 05/27/2021 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: ONCOLOGY | ||||||
| 03/09/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 85 | 141 | $61,055 | $13,030 |
| 2022 | 5 | 149 | 241 | $90,025 | $19,652 |
| 2021 | 5 | 213 | 383 | $180,784 | $34,556 |
| 2020 | 6 | 241 | 386 | $115,782 | $24,891 |
Total Patients
688
Total Services
1,151
Medicare Billing
$92,129
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 62 | $32,922 | $7,259 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 64 | $24,128 | $4,897 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 15 | $4,005 | $874.65 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 99 | $37,187 | $7,730 | 20.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 61 | $31,757 | $6,728 | 21.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 17 | 28 | $6,152 | $2,295 | 37.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 31 | 31 | $9,145 | $1,664 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 22 | $5,784 | $1,235 | 21.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 55 | 110 | $69,116 | $13,325 | 19.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 131 | $58,918 | $11,287 | 19.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 30 | 63 | $28,553 | $5,418 | 19.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 40 | 42 | $12,431 | $2,392 | 19.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 37 | $11,766 | $2,135 | 18.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 70 | 133 | $48,944 | $9,388 | 19.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 29 | 39 | $19,266 | $3,803 | 19.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 80 | $20,320 | $3,680 | 18.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 20 | 42 | $7,456 | $3,077 | 41.3% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 51 | 51 | $14,790 | $2,863 | 19.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 24 | 41 | $5,006 | $2,080 | 41.5% |
About Andrea Berry
Andrea Berry is a Nurse Practitioner healthcare provider based in Augusta, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2016. The National Provider Identifier (NPI) number assigned to this provider is 1265887921.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Andrea Berry has received a total of $621.96 in payments from pharmaceutical and medical device companies, with $261.65 received in 2024. These payments were reported across 17 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($423.01).
As a Medicare-enrolled provider, Berry has provided services to 688 Medicare beneficiaries, totaling 1,151 services with total Medicare billing of $92,129. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Augusta, ME
- Active Since 05/02/2016
- Last Updated 07/30/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1265887921
Products in Payments
- DARZALEX (Biological) $204.62
- OPDIVO (Biological) $63.57
- IMBRUVICA (Drug) $58.81
- MONJUVI (Drug) $30.70
- IMFINZI (Biological) $23.67
- Tavalisse (Drug) $23.46
- NINLARO (Drug) $22.76
- ADCETRIS (Biological) $20.87
- EPKINLY (Drug) $18.74
- Padcev (Drug) $15.07
- Lenvima (Drug) $13.85
- Optune Lua (NovoTTF-200T) (Device) $13.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Augusta
Mrs. Kristen Bradley, Fnp-Bc, FNP-BC
Nurse Practitioner — Payments: $8,738
Nurse Practitioner $8,738
Tamara Coleman, Dnp-Fnp, DNP-FNP
Nurse Practitioner — Payments: $7,123
Nurse Practitioner $7,123
Nicole Martinez De Andino, Np, NP
Nurse Practitioner — Payments: $5,593
Nurse Practitioner $5,593
Trisha Myers, Np, NP
Nurse Practitioner — Payments: $5,339
Nurse Practitioner $5,339
Mrs. Sarah Jimenez, Apn-C, Aocnp, APN-C, AOCNP
Nurse Practitioner — Payments: $3,858
Nurse Practitioner $3,858
Mrs. Davina Little, Aprn, APRN
Nurse Practitioner — Payments: $3,599
Nurse Practitioner $3,599